Table 2.
Sampling time | na | No. (%) of specimens positive at proposed cutoff of: |
||
---|---|---|---|---|
94 EU/ml | 125 EU/ml | 200 EU/ml | ||
Baseline | 102 | 0 (0) | 0 (0) | 0 (0) |
1 wk | 98 | 2 (2) | 0 (0) | 0 (0) |
2 wk | 96 | 6 (6.2) | 2 (2.1) | 1 (1) |
4 wk | 94 | 6 (6.4) | 3 (3.2) | 0 (0) |
3 mo | 57 | 2 (3.5) | 1 (1.8) | 0 (0) |
6 mo | 54 | 0 (0) | 0 (0) | 0 (0) |
9 mo | 47 | 0 (0) | 0 (0) | 0 (0) |
12 mo | 51 | 0 (0) | 0 (0) | 0 (0) |
18 mo | 43 | 0 (0) | 0 (0) | 0 (0) |
24 mo | 39 | 0 (0) | 0 (0) | 0 (0) |
Number of measurements available at each sampling time for the entire cohort. Note that for several subjects, specimens were not available for all sampling times between their prevaccination and last sampling times.